28/2/2024
•
By Cyril Gilbert
•
1 min read
We are thrilled to announce that Kimialys is part of Challenges' Challenges’ prestigious “Top 100 Startups Where to Invest” 2023 list.
This recognition highlights our team’s dedication to advance innovative diagnostic tests and support pharmaceutical companies in their drug development efforts. This achievement sets Kimialys as one of the most promising startups in its field, meeting the needs of the fast-growing in vitro diagnostic and biopharmaceutical industries.
For further information and to watch the 3 minute pitch of our CEO, Cyril Gilbert:
Subscribe to our monthly newsletter and stay informed about the latest news, application notes, and insights from our activities.
By clicking Sign Up you're confirming that you agree with our Terms and Conditions.